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Transcripts and/or proteins of P2X receptor (P2XR) subunits have been found in virtually
all mammalian tissues. Generally more than one of the seven known P2X subunits have
been identified in a given cell type. Six of the seven cloned P2X subunits can efficiently
form functional homotrimeric ion channels in recombinant expression systems. This is
in contrast to other ligand-gated ion channel families, such as the Cys-loop or glutamate
receptors, where homomeric assemblies seem to represent the exception rather than
the rule. P2XR mediated responses recorded from native tissues rarely match exactly
the biophysical and pharmacological properties of heterologously expressed homomeric
P2XRs. Heterotrimerization of P2X subunits is likely to account for this observed diversity.
While the existence of heterotrimeric P2X2/3Rs and their role in physiological processes
is well established, the composition of most other P2XR heteromers and/or the interplay
between distinct trimeric receptor complexes in native tissues is not clear. After a
description of P2XR assembly and the structure of the intersubunit ATP-binding site,
this review summarizes the distribution of P2XR subunits in selected mammalian cell
types and the biochemically and/or functionally characterized heteromeric P2XRs that have
been observed upon heterologous co-expression of P2XR subunits. We further provide
examples where the postulated heteromeric P2XRs have been suggested to occur in
native tissues and an overview of the currently available pharmacological tools that have
been used to discriminate between homo- and heteromeric P2XRs.
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ASSEMBLY OF P2XRs
TRIMERIC STRUCTURE OF P2XRs
Early electrophysiological measurements in bullfrog sensory neu-
rons and single channel analysis of HEK cell-expressed P2X2Rs
predicted that there are at least three ATP molecules needed
to open a P2X channel (Bean, 1990; Ding and Sachs, 1999).
Cross-linking studies and blue-native PAGE analysis of P2X1
and P2X3 receptors heterologously expressed in Xenopus laevis
oocytes revealed the first biochemical evidence for a trimeric qua-
ternary structure of P2XR channels (Nicke et al., 1998). This
rather unexpected architecture was subsequently confirmed by
atomic force microscopy (AFM) (Barrera et al., 2005), electron
microscopy (EM), single particle analysis (Mio et al., 2005; Young
et al., 2008) and finally the first crystal structure of a P2XR, the
truncated zebrafish zP2X4R (Kawate et al., 2009), which consti-
tuted a major breakthrough in P2XR research. Unexpectedly, the
crystal structure of the acid sensing ion channel (ASIC), a mem-
ber of the ENaC/DEG (epithelial sodium channels/degenerin)
superfamily, which shares the same topology and was published
around the same time by the Gouaux group, also revealed a
trimeric structure, although the two channels show no significant
amino acid sequence relationships or similarities in the folding of
their extracellular domains (Jasti et al., 2007; Gonzales et al., 2009;
Kawate et al., 2009).
The overlapping expression patterns of various P2X subunits,
the poor expression of functional P2X5 and P2X6 homomers
in heterologous systems (see below), and the lack of correlation
of the functional properties of heterologously expressed homo-
meric P2X3Rs with P2XRs found in dorsal root ganglions (Lewis
et al., 1995), have early led to the assumption that P2XRs, like
most ionic receptors, form heteromers. The existence of P2X het-
eromers is now firmly established but their specific composition
and presence in native tissues remains in most cases enigmatic
(see chapter Distribution of P2XR subunits). Likewise, their sto-
ichiometry and determinants for subtype specific assembly are
largely unclear. Biochemical and/or functional analysis of het-
erologously expressed P2X2/3 and P2X2/6 heteromers indicates a
fixed stoichiometry of P2X2(3)2 (Jiang et al., 2003) and P2X(2)26
(Hausmann et al., 2012), respectively. In contrast, a variable,
expression-level-dependent stoichiometry for P2X2/6 heteromers
was observed in atomic force imaging experiments (Barrera et al.,
2007). Co-purification experiments with the P2X1/2 heteromer
suggest a P2X1(2)2 stoichiometry (Aschrafi et al., 2004). So far,
no evidence has been presented for the formation of complexes
containing three different subunits.
ASSEMBLY DOMAINS AND MOLECULAR STRUCTURE OF THE P2XR
To investigate the role of the transmembrane domains (TMs)
in subunit assembly, Torres and colleagues performed co-
precipitation studies in HEK cells and found that the association
of P2X2 subunits with either itself or P2X3 subunits was pre-
vented if TM2 and the preceding 25 amino acids were deleted
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(Torres et al., 1999b). To confirm the hypothesis that TM2 rather
than the extracellular domain is critical for subunit assembly,
these investigators made use of the finding that P2X6 subunits
were able to co-immunoprecipitate with P2X1 but not P2X3 sub-
units (Torres et al., 1999a). Using chimeras in which the extracel-
lular loops between P2X1 and P2X3 subunits were swapped they
could demonstrate that only the chimera containing the P2X1
TMs was able to co-immunoprecipitate the P2X6 subunit. In a
subsequent study on the hP2X5R splice variant that lacks the C-
terminal end of the ectodomain and the outer half of the TM2, it
was shown that tethering of the C-terminal end of the ectodomain
bymembrane insertion of TM2 and the intramembrane position-
ing of D355 are critical for homotrimeric assembly (Duckwitz
et al., 2006). It was concluded that membrane insertion of TM2
restricts the conformational mobility of the ectodomain and thus
enables correct positioning of assembly recognition sites located
in the ectodomain, while D355 assists in the hydrogen bond-
driven transmembrane helix-helix associations. In the zP2X4R
crystal structure, however, it is seen that inter-subunit contacts
are largely formed between the ectodomains (Kawate et al., 2009).
The homotrimeric zP2X4R resembles a chalice, with the large
extracellular domain raising ∼70 Å above the membrane plane
and the six TM helices forming the shape of an hourglass. The
single zP2X4 subunit structure has been compared with the shape
of a jumping dolphin, in which the two TM helices and the
largest part of the extracellular region form the fluke and the
upper body, respectively. Attached to the large body domain, a
flexible head domain, a dorsal fin, and right and left flippers
have been defined. The body domain appears structurally rigid
due to extensive β-sheet contacts within a β-sandwich motif.
Three interfaces with close contact between adjacent subunits
were defined; upper-body-to-upper-body, head-to-body and left-
flipper-to-dorsal-fin. Thus, the contacts between neighboring
subunits are restricted to the upper ectodomains. The lack of sig-
nificant contacts between the lower bodies of the extracellular
domains enables significant movements in these domains dur-
ing ATP-induced channel opening (Kawate et al., 2009; Hattori
and Gouaux, 2012). It was suggested that the more conserved
body domains constitute a common assembly interface in all
P2XRs, while the less conserved dorsal fin, head, and left flipper
domains guide the subunit-specific assembly by the head-to-
body and left-flipper-to-dorsal-fin contacts (Kawate et al., 2009).
The low conservation of the latter domains has an important
consequence: While homotrimeric P2XRs contain three identi-
cal subunit-subunit interfaces, heteromeric P2XRs form always
three significantly different interfaces between the “head-to-tail”
arranged subunits (see also “Specific characteristics of the ATP
sites in heteromeric P2XRs”).
THE INTERSUBUNIT ATP-BINDING SITE
Most of the conserved amino-acid residues involved in the inter-
action with ATP have been identified in mutagenesis-based stud-
ies (Ennion et al., 2000; Jiang et al., 2000; Roberts and Evans,
2004; Yan et al., 2005; Roberts and Evans, 2006; Wilkinson et al.,
2006; Young et al., 2006; Fischer et al., 2007; Zemkova et al.,
2007; Roberts et al., 2008; Donnelly-Roberts et al., 2009; Evans,
2009; Roberts et al., 2009; Browne et al., 2010; Evans, 2010;
Bodnar et al., 2011). Based on disulfide cross-linking exper-
iments, in which some of these residues were substituted by
cysteine residues, it was concluded that the agonist binding
site is located at the interface between two neighboring sub-
units (Marquez-Klaka et al., 2007). Crystallization of the zP2X4R
showed that these residues surround a large intersubunit cavity,
which was proposed to constitute the ATP binding site. This cav-
ity is formed between two complementary half-shells contributed
by the adjacent subunits A and B.When viewed from the side (i.e.,
in parallel to the membrane plane), the upper left and the lower
right boundaries of each ATP-binding site are constituted by the
upper body and the left flipper of subunit A and the lower body
and dorsal fin of subunit B, respectively (Kawate et al., 2009). By
labeling of engineered cysteines with thiol-reactive ATP-analogs
(Jiang et al., 2011) and by voltage-clamp fluorometry studies
(Lörinczi et al., 2012), it was confirmed that this cavity constitutes
the ATP binding site and that the flexible head domain of subunit
A that projects over the binding site moves substantially during
ligand binding and/or channel gating (Hattori and Gouaux, 2012;
Jiang et al., 2012; Lörinczi et al., 2012). The zP2X4 structure pro-
vided a basis for rational mutant design, in silico docking, and
molecular dynamics simulations which were crucial to identify
the three lateral ion-access-pathways, and to improve our under-
standing of the molecular mechanisms of ligand binding and
channel gating (Jiang et al., 2010; Rokic et al., 2010; Allsopp et al.,
2011; Bodnar et al., 2011; Jiang et al., 2011; Kawate et al., 2011;
Samways et al., 2011; Wolf et al., 2011; Du et al., 2012a; El-Ajouz
et al., 2012; Jiang et al., 2012; Lörinczi et al., 2012; Roberts et al.,
2012; Hausmann et al., 2013). However, docking of ATP proved
difficult due to the spatial diversity of the ATP-binding pockets
of different P2X subtypes, the high flexibility of the critical lysine
residues, and a multitude of possible binding-modes within the
relatively large (compared to the ATP molecule) binding pocket.
The precise mode of ATP-binding was only determined by crys-
tallization of an ATP-bound zP2X4R (Hattori and Gouaux, 2012).
The phosphate chain and the adenine ring of the ATP molecule
are folded in an U-shaped configuration within the ATP-binding
pocket. The phosphate oxygens of ATP are coordinated by the
side chains of K70 and K72 within the lower body of subunit B
and N296, R298, and K316 within the upper body of subunit A
(zP2X4 numbering). In agreement with labeling experiments at
the P2X2R using a thiol-reactive ATP-analog (Jiang et al., 2011),
the adenine base of ATP is making hydrophobic interactions with
L191 of the lower body and I232 of the dorsal fin (subunit B). It is
further stabilized by hydrogen bonds with the side chain of T189
and the backbone of K70, both located within the lower body
of subunit B. The ribose moiety is facing the solution (Lörinczi
et al., 2012) and recognized solely by hydrophobic interactions
with L217 within the dorsal fin of subunit B (Hattori and Gouaux,
2012).
SPECIFIC CHARACTERISTICS OF THE ATP-BINDING SITES IN
HETEROMERIC P2XRs
Under the condition of similar conformations of the subunits
and their uniform arrangement (Kawate et al., 2009; Hattori and
Gouaux, 2012), three equivalent intersubunit ATP-binding sites
can be assumed in one homomeric P2XR. Based on the zP2X4
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structure, homology models of the ATP-binding sites of homo-
meric P2X1, P2X2, P2X3, P2X4, and P2X7 receptors have been
generated so far (Keceli and Kubo, 2009; Roger et al., 2010;
Allsopp et al., 2011; Bodnar et al., 2011; Jiang et al., 2011; Wolf
et al., 2011; El-Ajouz et al., 2012; Jiang et al., 2012; Lörinczi et al.,
2012; Roberts et al., 2012; Schwarz et al., 2012; Hausmann et al.,
2013). As outlined above, three significantly different intersub-
unit binding sites are formed in the case of heteromeric P2X
assemblies: one between two identical subunits and two at the
heteromeric interfaces A/B and B/A. The structural differences
of the latter two are mainly due to structural differences in the
upper bodies and left flippers as exemplarily shown for P2X2
and P2X3 subunits (Figure 1) and lead to different interfaces and
volumes of the hydrophilic cavities. In addition, the overlapping
head domains differ significantly in their backbone conformation
and side chain orientation. These domains are characterized by
a highly conserved pattern of three disulfide bridges that con-
strain the rather non-conserved sequences between the cysteine
residues in loops of different length and structure. Although these
domains do not directly contribute to ATP binding, they appear
to be important for channel gating and might have crucial influ-
ence on antagonist selectivities (Wolf et al., 2011; El-Ajouz et al.,
2012; Hattori and Gouaux, 2012; Jiang et al., 2012; Lörinczi et al.,
2012; Roberts et al., 2012). The side chains of residues responsible
for the coordination of ATP, e.g., as illustrated for selected basic
residues in Figure 1, are in different spatial orientation and in
unequal distances relative to each other. Evidence for varying dis-
tances and/or orientation of residues critical for ATP binding was
also obtained in cysteine cross-linking experiments at P2X1/P2X2
interfaces in the respective heteromer (Marquez-Klaka et al.,
2009). Here, co-expression of K68C-P2X1 and F289C-P2X2 sub-
units resulted in spontaneous intersubunit cross-linking, while
co-expression of F291C-P2X1 and K69C-P2X2 subunits did not
produce significant amounts of SDS-resistant dimers. As a con-
sequence of the spatial orientations, unequal binding sites are
formed where ligands likely adopt substantially different binding
modes and consequently different binding affinities and specifici-
ties. This is reflected in distinct pharmacological characteristics
of heteromeric and homomeric P2XRs (Gever et al., 2006; Jarvis
and Khakh, 2009; Coddou et al., 2011b) and may open the pos-
sibility for the development of ligands that are able to specifically
block heteromeric P2XRs. However, so far it is not known, if a
heteromeric P2XR can be blocked by specific targeting of one of
the two heteromeric ligand binding sites or how many binding
sites have to be occupied by antagonists to inhibit the channel.
COOPERATIVITY OF ATP BINDING IN P2XRs
Binding of agonist is supposed to induce channel opening by
a closing movement of the head domain that is further prop-
agated to the TM domains (Hattori and Gouaux, 2012; Jiang
et al., 2012; Lörinczi et al., 2012). Dose response curves for ATP
yield generally Hill-slopes greater than one (Bean, 1992; Brake
et al., 1994) indicating that more than one agonist molecule
binds before channel opening occurs. However, analyses of dose
response curves are deceptively complex (Colquhoun, 1998) and
the Hill-slope can only serve as a rough estimate of the minimum
number of binding sites. The reduced Hill coefficients observed
FIGURE 1 | Homology model of the closed state of the human
P2X2/3R. (A) A side view of the heterotrimeric hP2X2(3)2R in which both
heteromeric interfaces are visible is shown in the middle. The P2X2 subunit
is colored in cyan and the two P2X3 subunits are colored in orange and
pink. Selected basic residues important for ATP binding are shown as
spheres within the two intersubunit ATP-binding sites. For clarity, the same
residues are shown as sticks in a close-up view with depiction of the
distances between their side chains. (B) Frontal close-up views of the two
heteromeric ATP-binding sites with a partial transparent surface to indicate
the orientation of the residues. The coloring of the subunits is the same as
in (A). Differences in the three-dimensional structures and volumes of the
hydrophilic cavities are clearly seen. (C) Surface representations of the
same view as in (B) with gradual depiction of hydrophobic (green) or
hydrophilic (pink) areas/residues. Neutral areas are shown gradually white.
The hP2X2/3R homology model was generated and visualized by the
molecular modeling program MOE2012.10 (Molecular Operating
Environment 2012, CCG, Montreal, Canada) using the apo zP2X4 crystal
structure (PDB entry 3H9V; (Kawate et al., 2009) as a template as
previously described (Wolf et al., 2011; Hausmann et al., 2013).
for agonist dose response curves at heteromeric P2XRs (Torres
et al., 1998; Haines et al., 1999; Surprenant et al., 2000; Jiang
et al., 2003) might suggest that the heteromers require fewer ago-
nist molecules for opening but could also be explained by factors
like altered cooperativity or desensitization. From electrophys-
iological analysis and mathematical modeling of the activation
and deactivation kinetics of the P2X2, P2X3, and P2X7 recep-
tors it was concluded that two ATP molecules are sufficient to
open the channels while occupation of three binding sites enables
dilation of the pore in P2X2 and P2X7 subtypes (Karoly et al.,
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2008; Yan et al., 2010; Khadra et al., 2012). As detailed below,
co-expression of wt (wild type) P2X6 subunits rescued ATP-
elicited currents of P2X2 subunits with defective ATP-binding
sites. Since receptors with one non-functional ATP-binding site
can be activated, this supports the model in which binding of
two ATP molecules is sufficient for channel gating (Wilkinson
et al., 2006; Hausmann et al., 2012). Similar studies with con-
catenated subunits indicate that this is also valid for homomeric
P2X2Rs (Stelmashenko et al., 2012). In contrast, photoaffinity
labeling data at a homomeric non-desensitizing P2X2/1 chimera
are better described by a model in which three BzATP molecules
must bind to open the channel (Bhargava et al., 2012). In case
that binding of two ATP molecules is sufficient to induce chan-
nel opening, ATP would need to bind and induce closure of the
head domain in at least two of the three distinct ATP-binding
sites in heteromeric P2XRs. For antagonists, the situation is likely
different. Like in other ligand-gated ion channels, orthosteric
antagonists of P2XR are generally larger molecules and supposed
to block the closing movement or even induce an opening of the
ATP-binding pocket (Du et al., 2012b), thereby preventing the
initial gating step. Provided that simultaneous symmetric con-
formational changes of the three subunits should be favored,
it might depend on the size of antagonist if targeting of one
ATP binding sites is sufficient to prevent the ATP-induced gat-
ing of the whole trimeric channel. In case of the muscle-type
nAChR for example, it appears, that occupation of only one ago-
nist binding site by specific peptide antagonists is sufficient to
inhibit channel opening, although it has to be considered that
this channel has only two agonist binding sites (Groebe et al.,
1995).
PROPERTIES OF HETEROLOGOUSLY EXPRESSED P2XRs
HOMOMERIC EXPRESSION
When heterologously expressed, most mammalian P2X sub-
units readily form homotrimeric complexes with functional and
pharmacological properties described below. For P2X5Rs species-
specific differences in expression efficiency and functional prop-
erties such as ion permeability were observed (Collo et al., 1996;
Garcia-Guzman et al., 1996; Cox et al., 2001; Jensik et al., 2001;
Ruppelt et al., 2001; Diaz-Hernandez et al., 2002; Wildman
et al., 2002). This subunit occurs in humans predominantly as
a non-functional splice variant (Le et al., 1997; Bo et al., 2003;
Duckwitz et al., 2006) and expression of the mouse and rat iso-
forms is inefficient (Collo et al., 1996; Cox et al., 2001; Wildman
et al., 2002). For P2X6Rs, heteromerization with other subunits
appears to be obligatory for correct folding and trimeric assem-
bly (see below) (Collo et al., 1996; Soto et al., 1996b; Nawa
et al., 1998; King et al., 2000; Aschrafi et al., 2004; Barrera et al.,
2005).
P2XRs are generally classified in rapidly desensitizing (P2X1
and P2X3), and slowly or non-desensitizing (P2X2, P2X4, P2X5,
and P2X7) receptors although desensitization properties can
change under cell-free conditions (Ding and Sachs, 2000). For
P2X2, P2X4, and P2X7 receptors, additional permeability states
have been described (Khakh et al., 1999; Virginio et al., 1999a,b;
Khadra et al., 2012, 2013), for details see (Kaczmarek-Hajek et al.,
2012), which are little understood on the molecular level.
AGONIST PHARMACOLOGY OF HOMOMERIC P2XRs
As a recent and detailed review of P2XR pharmacology is available
(Coddou et al., 2011b), the following paragraphs summarize only
some of the key functional properties of homomeric P2XRs with a
focus on those characteristics that have been used to differentiate
homomeric and heteromeric P2XRs.
The EC50 values for ATP range from submicromolar concen-
trations for P2X1, P2X3, and P2X5 to lowmicromolar concentra-
tions for P2X2 and P2X4 receptors. At the P2X7R, EC50 values
for ATP range from about 0.1 to 1mM for the rat and mouse
isoforms, respectively. BzATP is at least one order of magnitude
more potent at this receptor (Rassendren et al., 1997) but has
also considerable activity at other P2X isoforms (Anderson and
Nedergaard, 2006). Agonist potency at P2X7Rs decreases if Ca2+
or Mg2+ are present in the recording solution. Ca2+ decreases the
potency of orthosteric agonists independently of the free agonist
concentration, thus acting as an allosteric inhibitor (Yan et al.,
2011). In the case of Mg2+, the inhibition seems to be due to both
an inhibitory Mg2+ binding site and a lower or absent agonist
activity of Mg2+-bound ATP at the P2X7R (Virginio et al., 1997;
Klapperstück et al., 2001; Acuna-Castillo et al., 2007). Differences
in the sensitivity to free ATP and Mg2+-bound ATP were also
reported for P2X2 and P2X4 receptors but not seen with P2X1,
P2X2/3, and P2X3 receptors (Li et al., 2013).
All P2XR agonists known so far are nucleotide analogs. ATPγS
and αβ-meATP are metabolically more stable and widely used
to investigate ATP-gated channels in native tissues. In addition,
2-MeSATP, diadenosine polyphosphates, and other nucleoside
triphosphates are used as P2X agonists. Interestingly, fast desen-
sitization and slow recovery from desensitization of P2X1R and
P2X3R seems to be associated with the formation of high-
affinity binding sites for ATP, αβ-meATP, and the antagonist
trinitrophenyl-ATP (TNP-ATP). At homomeric P2X2Rs, αβ-
meATP is an agonist with very low potency (EC50 >100μM),
while homomeric P2X4Rs are activated in a species-dependent
manner with EC50 values ranging from 5 to 100μM. P2X7Rs
are not readily activated by αβ-meATP (EC50 >> 100μM). In
heteromeric assemblies, P2X1, P2X3, P2X5, or P2X6 subunits
appear to confer αβ-meATP sensitivity. In contrast, the diadeno-
sine tetraphosphate Ap4A, is a full and potent agonist at the
homomeric P2X2R (Pintor et al., 1996; Wildman et al., 1999a),
but is inactive at the heteromeric P2X2/6R (King et al., 2000).
ANTAGONIST PHARMACOLOGY OF HOMOMERIC P2XRs
The large polysulfonated naphtylurea suramin and the pyridox-
alphosphate derivative PPADS are among the earliest and still
most widely used P2XR antagonists. Suramin also inhibits other
purinergic receptors and G-proteins and more specific analogs
(“NF compounds”) have been developed. Of these, NF449 is
highly selective for P2X1Rs and NF770 is moderately selective for
P2X2Rs. PPADS is a more specific inhibitor for P2 receptors but
acts in a non-competitive way. More potent analogs (“MRS com-
pounds”) with certain selectivity for P2X1 (MRS2220), P2X1 and
P2X3 (MRS2257), and P2X1, P2X3, and P2X7 (MRS2159) have
been developed (Coddou et al., 2011b).
The nucleotide analog TNP-ATP is a competitive antago-
nist with nanomolar affinity for recombinant P2X1, P2X3, and
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P2X2/3 receptors, and micromolar affinity for recombinant P2X2
and P2X4 receptors (King et al., 1997; Virginio et al., 1998).
Another nucleotide-based antagonist diinosine pentaphosphate
(IP5I) showed improved stability in native tissues and is a potent
and selective P2X1R antagonist (King et al., 1999). Oxidized ATP
is used as an irreversible P2X7 antagonist but requires exten-
sive pre-incubation. New types of mostly non-nucleotidic and
subtype-specific antagonist have been developed during the last
two decades. These efforts focused mainly on the P2X3 and
P2X7 subtypes that appeared to be the most relevant drug tar-
gets. Among others, the P2X3 and P2X2/3-selective antagonists
RO-51, RO-3, TC-P262, AF353 (RO-4), A-317491 and the P2X7-
selective antagonists A-438079, A-740003, A-804598, A-839977,
AZ 11645373, AZ 10606120 are commercially available. In partic-
ular for P2X7Rs, however, species specificity has to be considered.
The commonly used inhibitors KN-62 and BBG for example,
are selective for human and rat P2X7 isoforms, respectively
(Donnelly-Roberts et al., 2009).
At the P2X4R, which has been difficult to target, 5-BDBD has
been shown to be a comparably potent blocker (IC50 ∼ 0.5μM)
(Donnelly-Roberts et al., 2008) and very recently, PSB-12054 was
introduced as hP2X4R antagonist with submicromolar potency
(IC50 ∼ 0.2μM) (Hernandez-Olmos et al., 2012). In addition,
more specific P2X2-antagonists, the anthrachinone derivatives
PSB-10211 and PSB-1011, were introduced (Baqi et al., 2011).
ALLOSTERIC MODULATORS OF P2XRs
Acidification enhances responses of agonists and suramin at the
rat P2X2R (King et al., 1997). Likewise, P2X2/3 (Stoop et al.,
1997) and, with a distinct pattern, P2X2/6 (King et al., 2000)
and P2X1/2 (Brown et al., 2002) receptors are modulated by
protons (see below). Mutation of H319 to alanine removed the
potentiating effect of acidification on rat P2X2Rs (Clyne et al.,
2002). Its characteristic modulation by protons can help to dis-
tinguish P2X2Rs since all other homomeric P2XRs are inhibited
by acidification [for details see (Coddou et al., 2011b)].
Mg2+ was recently shown to directly inhibit P2X1, P2X3,
and P2X7 receptors, while P2X2 and P2X2/3 receptor responses
were insensitive or less sensitive to Mg2+ when activated by
supermaximal concentrations of free ATP (Li et al., 2013).
The trace metals Zn2+ and Cu2+ allosterically modulate
P2XRs in complex subtype- and species-specific ways and via
non-conserved binding sites [for details see (Coddou et al.,
2011a)]. In summary, Zn2+ inhibits P2X1 and P2X7 receptor
currents and modulates P2X2, P2X3, P2X4, and P2X5R currents
in a biphasic way, i.e., it potentiates at low concentrations and
inhibits at high concentrations. The Zn2+ binding site of the
rat P2X2R has been localized at the interface between adjacent
subunits (Nagaya et al., 2005). Like zinc, copper modulates the
rat P2X2R in a biphasic way, while the human P2X2R and the
P2X7R are only inhibited by zinc and copper (Tittle and Hume,
2008; Coddou et al., 2011a). A peculiarity of the P2X4R is that
it is differentially modulated by Zn2+ and Cu2+. While Zn2+and
Cu2+both coordinate at the inhibitory allosteric site, Zn2+ can
additionally bind to a positive allosteric site explaining the differ-
ent modulatory effects of zinc and copper at the P2X4R (Coddou
et al., 2003, 2007, 2011a).
The antiparasitic agent ivermectin (IVM) has agonist proper-
ties at invertebrate glutamate receptors (GluRs) and is also phar-
macologically active at a number of other ligand-gated ion chan-
nels. At homomeric and heteromeric P2X4Rs it is an allosteric
modulator (Khakh et al., 1999; Priel and Silberberg, 2004). In
the absence of efficient P2X4R inhibitors, it has been widely used
as a tool to dissect P2X4 subunit containing receptors. However,
more recent studies show that IVM can also species-specifically
potentiate P2X7R current amplitudes (Casas-Pruneda et al., 2009;
Surprenant and North, 2009; Nörenberg et al., 2010).
PHARMACOLOGY OF HETEROMERIC RECEPTORS
In most functionally characterized heteromers (see below) the
kinetic and ligand-binding properties of the constituting sub-
units are combined and the slowly desensitizing subunit generally
dominates the kinetic, while the subunit with higher affinity for
agonist and/or antagonist appears to increase the sensitivity of the
heteromer for the respective ligand.
In agreement with this, the P2X2/3 heteromer appears to adopt
largely the pharmacological profile (agonist potency, TNP-ATP
sensitivity) of the P2X3 subunit, which is present twofold within
the complex (Jiang et al., 2003). Although their stoichiometry is
not known, the P2X1/4R and the P2X1/5R also show a pharma-
cological profile more similar to the P2X1R and kinetic properties
that resemble the P2X4R or P2X5R, respectively (Coddou et al.,
2011b). The often slightly lower potency of agonists at the het-
eromers is too subtle for a true discrimination from the P2X1 or
P2X3 homomer and most likely reflects a lower affinity for ATP
at the heteromeric ATP-binding sites. In case of the heteromeric
P2X2/6 or P2X4/6 receptors the pharmacological properties are
similar to that of the P2X2R or P2X4R, respectively (Coddou
et al., 2011b). For the P2X2/6R a stoichiometry of two P2X2 and
one P2X6 subunits was suggested (Hausmann et al., 2012). The
heteromeric P2X1/2R shows a kinetic and pharmacological pro-
file that resembles the P2X1R, although a P2X1(2)2 stoichiometry
has been suggested (Aschrafi et al., 2004). However, it adopted the
pH sensitivity from the P2X2 subtype (Brown et al., 2002). The
H+ and Zn2+ sensitivity of the P2X2 subtype are also conferred
to the P2X2/3 and P2X2/6 heteromers (Li et al., 1996; Stoop et al.,
1997; King et al., 2000).
There are a few compounds that appear to be able to dis-
criminate between homomeric and heteromeric P2XRs. The
photoreactive [γ−32P]8-Azido-ATP is an effective agonist at
homomeric P2X3Rs but not at heteromeric P2X2/3Rs. It also
efficiently labeled homomeric P2X3Rs, but was inefficient at
homomeric P2X2Rs and heteromeric P2X2/3Rs (Koshimizu et al.,
2002). Likewise, Ip5I was shown to inhibit α,βme-ATP-induced
responses of homomeric P2X1 and P2X3 receptors with low
micromolar potency, but is virtually inactive at the heteromeric
P2X2/3R and the homomeric P2X2R (King et al., 1999; Dunn
et al., 2000). Also RO-85, an orally bioavailable drug-like P2X3R
antagonist, is selective for the P2X3R over the P2X2/3R and other
P2XR subtypes (Brotherton-Pleiss et al., 2010). Interestingly, all
these substances appear to lose their affinity at the heteromeric
receptor despite the fact that at least one P2X3-P2X3 interface is
preserved in the heteromer. Possible explanations for this discrep-
ancy would be, that the P2X3-P2X3 interface is markedly altered
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by inclusion of the single P2X2 subunit in the complex and/or
that occupation of one interface is insufficient and more than
one ligand has to bind to produce an efficient channel block. So
far, no compound has been identified, that is selective for any of
the heteromeric receptors. Thus, it remains questionable, if the
two requirements for selective heteromer targeting (1) selective
binding to one (or both) heteromeric interfaces and (2) efficient
blockade of the whole receptor by occupation of one (or both)
heteromeric interface(s) can be fulfilled. In case of small antago-
nists, the specific recognition area (contributed by both subunits)
might be too small and the critical lysine residues too flexible
to allow high selectivity. Also, the small ligand volume and the
comparably few interactions with both subunits might not pro-
vide sufficient steric hindrance to allosterically block the gating
movements in all three subunits.
In this regard, it is also important to consider that P2XRs dif-
fer substantially from other ligand-gated ion channels in having
three intersubunit ion access pathways that widen during chan-
nel opening (Kawate et al., 2011; Samways et al., 2011; Hattori
and Gouaux, 2012; Roberts et al., 2012). In combination with
the high flexibility of the lower ectodomains and their linkers
to the TMs, this might enable P2XRs to tolerate or compensate
also more or less pronounced antagonist induced conformational
changes before a complete channel block occurs.
DISTRIBUTION OF P2XR SUBUNITS
Although transcripts for more than one P2X subunit are found
in most cell types (Table 1), there is good evidence (in particu-
lar from studies on knockout mice) for homomeric P2X1, P2X2,
P2X3, P2X4, and P2X7 receptors in at least some native tissues
(e.g., Cockayne et al., 2005; Finger et al., 2005; Sim et al., 2007;
Nicke, 2008). However, properties of heterologously expressed
homomeric P2XRs more often do not match with those observed
in native tissues. In addition to the heteromers described below
and yet unidentified combinations of two or three different P2X
subunits, splice variants and interacting proteins most likely
contribute to the diversity of P2XR signaling.
HETEROOLIGOMERIZATION OF P2XR SUBUNITS
In a systematic biochemical analysis of pairwise co-expressed
Flag- and HA-tagged rat P2X subunits in HEK cells (Torres
et al., 1999a) it was found that (a) all subunits, except for
P2X6 subunits, were able to homo-oligomerize (see also Aschrafi
et al., 2004; Barrera et al., 2005), (b) P2X7 subunits did not
hetero-oligomerize with other subunits (see also Nicke, 2008;
Boumechache et al., 2009), and (c) the following pairs could
be mutually co-purified: P2X1/2∗, P2X1/3, P2X1/5∗, P2X1/6,
P2X2/3∗, P2X2/5∗, P2X2/6∗, P2X3/5, P2X4/5, P2X4/6∗, and
P2X5/6. Heteromerization between P2X4 and P2X5 subunits was
recently confirmed in an ELISA assay where a strong increase
in the surface expression of a trafficking deficient P2X5 mutant
by co-expression of the P2X4 subunit was observed (Compan
et al., 2012). However, this heteromer has not been further char-
acterized so far. In addition, P2X1/4∗ and P2X4/7∗ pairs were
identified in co-purification studies (Nicke et al., 2005; Guo
et al., 2007). Pairs marked with ∗ have also been functionally
investigated and partly confirmed in additional studies that are
described below. It has to be noted, however, that the differentia-
tion of a heterotrimeric assembly between two given subunits or
association of their respective homotrimeric complexes can gen-
erally not be achieved by standard co-purification protocols. In
particular, in case of the P2X4/P2X7 interaction, data from more
detailed biochemical analysis are in favor of the latter (Nicke,
2008; Antonio et al., 2011).
P2X1/2 HETEROMERS
Biochemical evidence
Biochemical evidence for heteromeric P2X1/2Rs was further
confirmed by studies in Xenopus laevis oocytes. In blue-native
(BN)-PAGE and disulfide cross-linking studies, the metaboli-
cally labeled heterotrimeric P2X1/2R complexes were directly
visualized and discriminated by their size from the respec-
tive homomers (Aschrafi et al., 2004; Marquez-Klaka et al.,
2009). These data clearly excluded the possibility that the co-
purification experiments were biased by artificial aggregation
of the overexpressed protein or clustering of homotrimeric
receptors (see below). Interestingly, no homotrimeric His-P2X1
complexes were detected in the BN-PAGE study and func-
tional analysis of the receptors formed from substituted cys-
teine mutant P2X1 and P2X2 subunits revealed no current
corresponding to homomeric P2X1Rs unless this subunit was
injected in more than 6-fold excess. This suggests that in the
presence of P2X2 subunits, the P2X1 subunit assembles pref-
erentially as heteromer. However, discrepancies in the amount
and speed in which the subunits are expressed could also
account for this observation. Further analysis of the selec-
tively radioiodinated heteromers in the plasma membrane
revealed significantly more radioactivity in the band corre-
sponding to the P2X2 subunit than in the His-tagged P2X1
subunit, suggesting a P2X1(2)2 stoichiometry (Aschrafi et al.,
2004).
Functional evidence
In a carefully conducted study by Brown et al. (2002) the
subtle differences between the fast desensitizing homomeric
P2X1R and the heteromeric P2X1/2R could be discriminated
by their sensitivity to extracellular pH. In contrast to P2X1
homomers, which show decreased agonist potency at acidic
pH and are not affected by alkaline pH, agonist efficacy at
the P2X1/2 heteromer is increased under both alkaline and
acidic pH (Brown et al., 2002). In contrast to the biochemi-
cal studies, hetero-oligomerization was found to be inefficient
in this study and only one in six oocytes showed the pH-
potentiated P2X1-like responses. The difficulty to resolve the
P2X1/2 heteromer current could be partly overcome by spe-
cific disulfide cross-linking of oocyte-expressed P2X1 and P2X2
mutants resulting in non-functional P2X1/2Rs and their acti-
vation following reduction with dithiothreitol (Marquez-Klaka
et al., 2009). However, the reduced agonist sensitivity in these
mutants has to be considered. The fast desensitizing pheno-
type found for the P2X1/2 heteromer is somehow exceptional
because in all other functionally described P2X heteromers the
slowly desensitizing subunit determines the kinetic of the het-
eromer.
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Table 1 | Summary of the distribution of P2XR subunits in selected mammalian cell types.
Cell line/type Identified transcripts Identified protein Functional data similar to
1 2 3 4 5 6 7 1 2 3 4 5 6 7
T-cells: Jurkat cell line(1) (+) + + (+) + + + Ca2+ imaging, siRNA: P2X1,
P2X4, P2X7
T-cells: human primary
CD4+(1)
(+) + + + + + Pharmacological inhibition,
Ca2+ imaging: P2X1, P2X4
Mast cells: LAD2 and
human lung mast cells(2)
+ + (+) + Patch clamp: P2X1, P2X4,
P2X7
Freshly isolated mouse
peritoneal
macrophages(3,4,46)
(+) + + + + KO mouse: P2X1, P2X4
J774 cells(5) + + (+) + + + + + Ca2+ imaging, patch clamp:
P2X4, P2X7
Mouse spleen
macrophages(5)
+ + + + + (+) (+) + + + + +
Human B
lymphocytes(6,7)
+ + + + + + +
HeLa cells(8) (+) + + + + + Ca2+ imaging, changes in
ATP-induced apoptosis: P2X7
Myocytes from renal
artery(9)
+ + Patch clamp: P2X1, P2X1/4
Endothelial cells(10,11,12) + + (+) + + + Ca2+ imaging: P2X4; KO
mouse: P2X4, P2X1;
patch-clamp: P2X7
Dorsal root ganglia (DRG)
neurons(13,14,15,16,17)
+ a + + + + + Patch clamp: P2X3, P2X2/3;
KO mouse: P2X3, P2X2,
P2X2/3
Nodose ganglia
neurons(13,15)
+ + + + + Patch clamp, KO mouse:
P2X2, P2X2/3
Superior cervical ganglion
(SCG) neurons(13,18,19)
(+) + + + + + (+) + + (+) + + Patch clamp, Ca2+ imaging:
predominantly P2X2; KO
mouse: P2X1
Urinary bladder afferent
neurons(15,20,21,22)
+ + Bladder function, patch
clamp: P2X3, P2X2/3; KO
mouse: P2X2, P2X3, P2X2/3
P19 cells(23,24,25,26) Ca2+ imaging: P2X2, P2X2/6,
P2X4; RNAi: P2X2, P2X7
Undifferentiated (+) + + + (+) (+) (+) (+) + (+)
Differentiated to
progenitors
(+) + (+) (+) + + + (+) + (+) (+) + (+)
Neuronally differentiated
neural progenitors(27)
+ (+) (+) (+) +
Astrocytes(28,29,30,31) + (+) + + + + + + + + + + + Patch clamp: P2X1/5;
YO-PRO uptake, RNAi: P2X7
Microglia(32,33,34,34,35,36,46) Nerve injury, KO mouse:
P2X4; patch clamp: P2X4,
P2X7; YO-PRO uptake: P2X7
Freshly isolated (+) + +
Primary culture + +
BV-2 cells + + + +
C8-B4 cells (+) + + + +
(Continued)
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Table 1 | Continued
Cell line/type Identified transcripts Identified protein Functional data similar to
1 2 3 4 5 6 7 1 2 3 4 5 6 7
Oligodendrocytes(38) + Ca2+ imaging: P2X7
Oligodendrocytes
(progenitors)(37)
+ + + + + Ca2+ imaging, patch
clamp: P2X7
Human salivary gland epithelial
(HSG) cells(39)
+ + + + + +
Human embryonic kidney (Hek)
293 cells(39)
Normal conditions (+) (+)
Grown past confluence + + + + +
Vascular smooth muscle
cells(40,41,42)
+ + + + b + c + + + Patch clamp: P2X1b
Non-cystic fibrosis epithelial
cells (16HBE14o−)(43)
+ + +
Cystic fibrosis cells (IB3-1)(43) + + + + + + RNAi, Ca2+ imaging: P2X4,
P2X6
Adrenal gland
pheochromocytoma (PC12)
cells(44,45)
Patch clamp, Ca2+
imaging: P2X2
Undifferentiated + +
NGF-differentiated + + + + + + + + + + + + + +
aExcept primates, bexcept septal vessels, cexcept cerebral vessels.
References in table: 1Woehrle et al., 2010a; 2Wareham et al., 2009; 3Sim et al., 2007; 4Ulmann et al., 2010; 5Coutinho-Silva et al., 2005; 6Sluyter et al., 2001;
7Wang et al., 2004; 8Welter-Stahl et al., 2009; 9Harhun et al., 2010; 10Yamamoto et al., 2000; 11Harrington et al., 2007; 12Wilson et al., 2007; 13Lewis et al., 1995;
14Cockayne et al., 2000; 15Cockayne et al., 2005; 16Compan et al., 2012; 17Serrano et al., 2012; 18Xiang et al., 1998, 19Calvert and Evans, 2004; 20Vlaskovska et al.,
2001; 21Zhong et al., 2001; 22Zhong et al., 2003; 23Da Silva et al., 2007; 24Resende et al., 2007; 25Resende et al., 2008; 26Yuahasi et al., 2012; 27Schwindt et al.,
2011; 28Franke et al., 2001; 29Kukley et al., 2001; 30Lalo et al., 2008; 31Yamamoto et al., 2013; 32Tsuda et al., 2003; 33Qureshi et al., 2007, 34Raouf et al., 2007;
35Ulmann et al., 2008; 36Toulme et al., 2010; 37Agresti et al., 2005; 38Matute et al., 2007; 39Worthington et al., 1999; 40Nori et al., 1998; 41Lewis and Evans, 2000;
42Lewis and Evans, 2001; 43Liang et al., 2005; 44Michel et al., 1996; 45Sun et al., 2007; 46Hickman et al., 2013.
Evidence from native systems
The solid biochemical evidence for P2X1/2 heteromers is in
contrast to the very limited evidence for this heteromer in native
tissues. P2X1 and P2X2 subunits are widely distributed and over-
lap in many tissues (Burnstock and Knight, 2004). Transcripts of
both subunits were found for example in vascular smooth muscle
(Nori et al., 1998). However, generally, expression levels differed
greatly, suggesting at most a small contribution of the respective
heteromer. Whole-cell patch clamp and calcium imaging stud-
ies in mouse sympathetic neurons revealed a dominant P2X2-like
phenotype and an αβ-meATP-sensitive receptor population that
was largely absent in P2X1 knockout mice (Calvert and Evans,
2004). This αβ-meATP-sensitive current was blocked by Ca2+
and alkaline pH and it was concluded that it corresponds to a
P2X1/2 heteromer. However, involvement of a third subunit was
suggested since the current was not potentiated at acidic pH and
showed a relatively slow time course of response.
P2X1/4 HETEROMERS
Biochemical evidence
Biochemical evidence for heteromerization between co-
expressed P2X1 and P2X4 subunits was excluded in two
co-immunoprecipitation studies performed in HEK cells (Le
et al., 1998; Torres et al., 1999a), but was later found by co-
purification and subsequent BN-PAGE analysis of Xenopus
oocyte-expressed P2X1 and P2X4 subunits (Nicke et al., 2005).
Functional evidence
Functional evidence for the formation of P2X1/4 heteromers
came from the generation of a new phenotype upon co-
expression of P2X1 and P2X4 subunits in Xenopus oocytes (Nicke
et al., 2005). The proposed P2X1/4 heteromer shares the mod-
erately desensitizing kinetics and fast recovery upon repeated
activation with the P2X4R. In contrast to the P2X4 homomer
and in common with the P2X1 homomer, however, it is activated
by low micromolar concentrations of αβ-meATP and inhibited
by suramin and TNP-ATP. Although these currents were repro-
ducibly found upon co-expression of both subunits, they were
comparably small, suggesting that previous attempts to detect
this heteromer failed due to preferential homomerization of both
subunits.
Evidence from native systems
While heterologously expressed P2X4Rs are efficiently expressed
as homotrimers in the plasma membrane, only few native
receptors have been identified that resemble exactly the
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recombinant homomeric P2X4R, which is relatively insensitive
to αβ-meATP (Coddou et al., 2011b). A possible explanation
is that both P2X4R expression and its cycling between intra-
cellular compartments and the plasma membrane are highly
dynamic and a predominant localization of P2X4Rs in intracel-
lular compartments has been described (e.g., Bobanovic et al.,
2002; Qureshi et al., 2007; Stokes and Surprenant, 2009; Toulme
et al., 2010). Thus, P2X4Rs appear to be expressed and/or translo-
cated to the plasma membrane only under specific conditions
(e.g., upon activation of microglial cells) and might require
additional subunits to be stabilized at the plasma membrane.
Receptors incorporating P2X4 subunits have been postulated in
a wide variety of tissues but little evidence for a P2X1/4 het-
eromer in native tissues has been provided so far. The P2X4
subunit has the widest distribution pattern of all P2X sub-
units and overlap with P2X1 subunits is found in many tissues.
For example, P2X1 and P2X4 subunits have been identified in
different types of immune cells (Sim et al., 2007; Wareham
et al., 2009; Woehrle et al., 2010b) and both subunits translo-
cate to the immune synapse in stimulated T cells (Woehrle et al.,
2010a). However, data from knockout mice (Sim et al., 2007)
and pharmacological analysis (Wareham et al., 2009) indicate
the presence of homomeric rather than heteromeric P2X1 and
P2X4Rs in mouse macrophages and human mast cells, respec-
tively. Co-expression of both subunits was also found by single
cell RT-PCR in smooth muscle cells of renal resistance arter-
ies (Harhun et al., 2010). Here, the characteristics of a current
component that was insensitive to the P2X1 antagonist NF279
(Rettinger et al., 2000) were consistent with the properties of
the P2X1/4 heteromer. A role of a P2X1/4 heteromer was also
considered in neurogenic contractions in the guinea pig urinary
bladder (Kennedy et al., 2007) and not excluded in coronary
artery smooth muscle (Conant et al., 2008) and erythrocytes
(Skals et al., 2009).
P2X1/5 HETEROMERS
Biochemical evidence
Biochemical evidence for the formation of heteromers consisting
of P2X1 and P2X5 subunits was initially obtained from HEK293
cells transfected with epitope-tagged P2X1 and P2X5 subunits
(Torres et al., 1998; Le et al., 1999). Here, the authors could
demonstrate a direct association by co-purification. However,
further biochemical evidence for P2X1 and P2X5 subunit inter-
action is still lacking in other in vitro models as well as in native
tissues.
Several studies provide functional evidence for heteromeriza-
tion of rat P2X1 and P2X5 subunits upon expression of both
subunits in established expression systems like Xenopus laevis
oocytes (Le et al., 1999; Rettinger et al., 2005) and cultured
HEK293, CHO, and COS cells (Torres et al., 1998; Haines et al.,
1999; Surprenant et al., 2000). The P2X1/5 heteromer shows dis-
tinct functional properties providing clear characteristics for its
identification: (a) In contrast to the P2X1 homomer, its cur-
rents have a biphasic kinetic with a desensitizing peak and a
non-desensitizing plateau current that are not desensitized by
repeated agonist application. Depending on pH and ATP con-
centrations, the current response kinetics of the P2X1/5R differ
(Surprenant et al., 2000). (b) It has a significant greater amplitude
than the P2X5 homomer and, similar to the P2X1R, is activated by
nanomolar ATP concentrations as well as by α,β-meATP (Torres
et al., 1998; Haines et al., 1999; Le et al., 1999). (c) PPADS,
suramin, and the specific P2X1R blocker NF449 antagonize with
similar micromolar potencies the P2X1/5 heteromer and the
P2X1 homomer (Haines et al., 1999; Rettinger et al., 2005), while
the potency of TNP-ATP at the heteromer is markedly reduced
in comparison to the P2X1 homomer and is more similar to
that at the P2X5 homomer (Haines et al., 1999; Surprenant
et al., 2000; Wildman et al., 2002). (d) A rebound current upon
removal of agonist has been observed in some studies (Haines
et al., 1999; Lalo et al., 2008). Peak currents of homomeric
P2X5Rs are drastically decreased in a Ca2+ concentration depen-
dent manner, whereas P2X1R responses are Ca2+ insensitive.
Interestingly, increased extracellular Ca2+ significantly potenti-
ated the steady-state currents of the P2X1/5 heteromer (Haines
et al., 1999). Both acidification and alkalization have inhibitory
effects on P2X1/5 heteromers while the homomeric receptors are
only inhibited by an increased proton concentration (Surprenant
et al., 2000).
Evidence from native systems
In contrast to the widely distributed expression of the P2X1
subunit, P2X5 subunit RNA has only been detected in a restricted
number of tissues including the heart, sensory andmotor neurons
of the cervical spinal cord (Collo et al., 1996), vascular smooth
muscle (Phillips and Hill, 1999), and astrocytes (Lalo et al., 2008).
The presence of P2X1/5 heteromers was suggested in guinea-pig
submucosal arterioles where an increase in spontaneous exci-
tatory junction potentials and higher current amplitudes were
measured following repetitive ATP application and increased
Ca2+ concentration, respectively (Surprenant et al., 2000). The
electrophysiological profile of this smooth muscle tissue supports
rather the presence of P2X1/5 heteromers than P2X1 homo-
mers that has been described in HEK293 cells expressing P2X1
and P2X5 subunits. In more recent studies, based on quanti-
tative real time PCR and pharmacological characterization by
whole cell voltage clamp experiments, evidence for P2X1/5Rs
in acutely isolated cortical astrocytes was obtained (Lalo et al.,
2008). Here, the heteromer appears to be involved in astrocytic
excitability, which is driven by phosphoinositides and mediated
through the lipid-binding domain of the P2X1 subunit (Ase et al.,
2010).
P2X2/3 HETEROMERS
The P2X2/3 heteromer was the first one to be identified func-
tionally and biochemically (Lewis et al., 1995; Radford et al.,
1997). So far, it represents the best characterized P2X het-
eromer and solid evidence for its in vivo expression in sensory
neurons and its functional role in sensory neurotransmission
exists. As several valuable reviews regarding their presence in
sensory and autonomic neurons and their physiological impor-
tance are available (North, 2002; Brederson and Jarvis, 2008;
Burnstock, 2009a; Jarvis, 2010; Khakh and North, 2012), this
chapter focuses only on some key findings and more recent
studies.
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Biochemical evidence and stoichiometry
Evidence for heteromerization of P2X2 and P2X3 subunits
was first obtained from co-immunoprecipitation studies of
P2X2 and P2X3 subunits heterologously expressed in Sf9 insect
cells (Radford et al., 1997). Subsequent co-precipitation stud-
ies by Torres et al. (1999b) confirmed the interaction of P2X2
and P2X3 subunits in HEK cells and more recently, BN-
PAGE analysis of oocyte-expressed affinity-tagged hP2X2 and
hP2X3 subunits demonstrated that both subunits co-assemble in
trimeric P2X2/3Rs, which are efficiently expressed at the plasma-
membrane (Hausmann et al., 2012). By analysis of disulfide bond
formations between engineered cysteine residues in P2X2 and
P2X3 subunits a “head-to-tail” subunit arrangement was origi-
nally demonstrated (Jiang et al., 2003). Furthermore, this study
revealed the presence of adjacent P2X3 subunits but not P2X2
subunits, indicating a P2X2(3)2 stoichiometry of P2X2/3 chan-
nels. This stoichiometry was further confirmed by co-expression
and functional analysis of P2X2 or P2X3 subunits containing sin-
gle or double mutated ATP binding sites (Wilkinson et al., 2006).
The P2X2(3)2 stoichiometry is indirectly supported by the find-
ing that the degree of potentiation by extracellular Zn2+ in the
P2X2/3 heteromer was comparable to the limited Zn2+ effect seen
with concatenated P2X2 trimers that contained only one wild
type subunit with two Zn2+ binding site mutants (Nagaya et al.,
2005).
Functional evidence
Functional evidence for the formation of P2X2/3 heteromers
came initially from patch clamp analysis and comparison of
rat nodose ganglia neurons and heterologously expressed P2X2
and P2X3 subunits (Lewis et al., 1995). This study revealed
a non-desensitizing, αβ-meATP sensitive functional phenotype
that could be unambiguously discriminated from the non-
desensitizing α,β-meATP insensitive P2X2 and the fast desensitiz-
ing α,β-meATP sensitive P2X3 phenotypes. In addition, similar
to the homomeric P2X2R, the heteromeric P2X2/3R is strongly
potentiated at low pH values, while the homomeric P2X3R is
much less pH sensitive and inhibited at low pH (King et al., 1996;
Stoop et al., 1997; Wildman et al., 1999b). For a more detailed
analysis of the pharmacologic and kinetic properties of heterolo-
gously expressed P2X2/3Rs see (Stoop et al., 1997; Virginio et al.,
1998; Burgard et al., 2000; Liu et al., 2001; Spelta et al., 2002,
2003).
Evidence from native systems
Evidence from native systems led initially to the identification
of heteromeric P2X2/3Rs; α,βme-ATP-elicited current responses
in nodose ganglia neurons did not match those of any singly
expressed P2X subunit but were reproduced by co-expression
of P2X2 and P2X3 subunits (Lewis et al., 1995). Subsequently,
convincing evidence for the existence of heteromeric P2X2/3
channels was also provided in sympathetic, trigeminal, and dor-
sal root ganglia neurons (Cook et al., 1997; Thomas et al.,
1998; Burgard et al., 1999; Grubb and Evans, 1999; Ueno et al.,
1999; Dunn et al., 2000, 2001; Lalo et al., 2001; Zhong et al.,
2001; Petruska et al., 2002). Functional analysis of P2X2 and
P2X2/P2X3 knockout mice further demonstrated/confirmed the
presence of P2X2/3Rs in sensory and autonomic ganglia neu-
rons and primary afferent nerve fibers in the urinary bladder
(Cockayne et al., 2005) and defined the relative contribution
of homomeric P2X2Rs and P2X3Rs and heteromeric P2X2/3Rs.
This study revealed that ATP-induced currents in dorsal root gan-
glia (DRG) neurons are mediated by P2X3 and P2X2/3Rs, while
those in nodose ganglion neurons are dominated by P2X2Rs and
P2X2/3Rs. In sympathetic ganglion neurons, P2X3-containing
receptors appear to be of minor functional importance and
in the urinary bladder, P2X3Rs and P2X2/3Rs regulate uri-
nary bladder reflexes. For more details about the role of these
receptors in afferent sensory neurotransmission, mechanosen-
sory transmission, and pain states see more recent reviews
(Wirkner et al., 2007; Burnstock, 2009b; Jarvis, 2010; Burnstock
et al., 2011; Khakh and North, 2012). Interestingly, a recent
study by Serrano and colleagues showed that in contrast to
rodent DRGs, P2X2 transcripts are virtually absent in human
and monkey DRG neurons (Serrano et al., 2012). Hence, pri-
mate DRG neurons seem to be devoid of P2X2/3Rs and ATP-
induced responses are mediated exclusively by P2X3Rs. This
finding may significantly affect the translatability of rodent
data to validate these receptors as targets for the treatment of
pain. P2X2 and P2X3 subunits are also co-expressed in sen-
sory nerve fibers in taste buds (Bo et al., 1999) and gustatory
nerves and P2X2/P2X3 double-knockout mice exhibited abol-
ished responses to taste stimuli (Finger et al., 2005; Eddy et al.,
2009).
P2X2/5 HETEROMERS
Biochemical evidence
The rat P2X2/5 heteromer represents the most recent addition
to the functionally characterized set of P2X subtypes. Apart
from co-immunoprecipitation studies, biochemical evidence for
its existence was provided by an ELISA assay that measured
the increase in plasma membrane appearance of an HA-tagged
trafficking-deficient P2X2 or P2X5 subunit by co-expression of
the respective other subunit. In addition, their close spatial
proximity was shown in bioluminescent resonance energy trans-
fer studies and in bimolecular fluorescence complementation
studies. In combination with cross-linking experiments using
a membrane-impermeable cross-linker and native perfluorooc-
tanoic acid (PFO)-PAGE analysis, these experiments indicated
that P2X2/5 heterotrimers appear with both possible stoichiome-
tries in the plasma membrane (Compan et al., 2012).
Functional evidence
Functional evidence for this heteromer was obtained upon co-
expression of both subunits in Xenopus oocytes and HEK cells
(Compan et al., 2012). Although the presence of homomeric
P2X2Rs could not be prevented, these studies revealed a novel
phenotype in oocytes with slightly reduced sensitivity to ATP,
ATPγS, and BzATP. Interestingly, BzATP showed strongly reduced
efficacy at this heteromer. Inhibition of the supposed heteromer
by TNP-ATP was increased while αβ-meATP was ineffective at
concentrations of 300μM. Co-expression of both subunits in
oocytes and/or HEK cells also produced ATP-activated time-
dependent permeability changes for NMDG, YO-PRO-1, and
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ethidium that showed a clearly different time course compared
to homomeric P2X2Rs and higher absolute fluorescence values
or even no saturation. Most remarkably, HEK cells co-expressing
both subunits displayed plasma membrane blebbing and flipping
of phosphatidylserine from the inside surface of the plasmamem-
brane to the outside surface (PS flip), two hallmark properties of
the P2X7R that were not seen in cells expressing P2X2 subunits
alone.
Evidence from native systems
Based on co-immunoprecipitation data from total brain and
brain stem as well as immunohistochemistry data from dorsal
root ganglia, spinal cord and trigeminal mesencephalic nucleus
neurons in the mid pons, the presence of P2X2/5 heteromers
in these tissues was suggested (Compan et al., 2012). However,
the P2X2/5 heteromer differs from a previously characterized
P2XR in trigeminal mesencephalic nucleus in its insensitivity to
α,β-meATP (Patel et al., 2001).
P2X2/6 HETEROMERS
Biochemical evidence and stoichiometry
Evidence for the interaction of P2X2 and P2X6 subunits was ini-
tially obtained by co-immunoprecipitation (Torres et al., 1999a)
andmore recently, heterotrimerization of these subunits was con-
firmed by BN-PAGE analysis of oocyte expressed affinity-tagged
hP2X2 and hP2X6 subunits (Hausmann et al., 2012). In con-
trast, to the heterotrimeric hP2X2/6 complex that is efficiently
expressed at the plasma membrane, hP2X6 subunits do not form
trimeric complexes (Aschrafi et al., 2004; Hausmann et al., 2012)
and are retained in the ER. In HEK cells, co-expression of wt
P2X6 subunits rescued ATP-elicited currents of P2X2 subunits
harboringmutations in ATP-binding residues (such as K69A) that
lead to the formation of non-functional homomeric P2X2Rs. Co-
expression of wt P2X2 subunits with mutant P2X6 subunits and
vice versa revealed that functional P2X2/6 heteromers consist of
two P2X2 subunits and one P2X6 subunit. The P2X(2)26 sto-
ichiometry is in contrast to an AFM study of antibody-tagged
isolated receptors, in which a variable subunit stoichiometry that
depended on the relative subunit expression levels was observed
(Barrera et al., 2007). However, in this study receptors puri-
fied from a crude membrane fraction, which also contained
intracellular membranes, were analyzed.
Functional evidence
Functional evidence for the existence of a P2X2/6 heteromer was
initially shown in Xenopus oocytes (King et al., 2000). Expression
of P2X6 subunits alone did not produce functional channels.
Co-expression of both subunits resulted in ATP-induced cur-
rents that had fast activating and slowly desensitizing kinetics
similar to homomeric P2X2Rs, but showed a biphasic current
decay upon removal of ATP. In a subset of cells, an additional
transient current component was present that was never seen in
oocytes expressing exclusively the P2X2 subunit. Another remark-
able difference is the loss of the agonist activity of Ap4A, which
is a full agonist at the P2X2R, but was almost inactive at the
P2X2/6 heteromer (King et al., 2000). In contrast to homo-
meric P2X2Rs, which exhibit a current amplitude potentiation
at high proton concentrations, heteromeric P2X2/6Rs showed a
decreased current amplitude at acidic pH. In HEK cells, how-
ever, the co-expression of a four-fold excess of the P2X6 subunit
with the P2X2 subunit revealed a current that was potentiated at
decreasing pH values and that was not seen in HEK cells express-
ing exclusively P2X2 subunits (Hausmann et al., 2012). Thus, the
cellular background might influence these properties.
Evidence from native systems
Co-expression of P2X2 and P2X6 transcripts has been described
in some nuclei of the thalamus and hypothalamus and in spe-
cific laminae of the pineal gland (Collo et al., 1996). P2X2 and
P2X6 subunits are also co-expressed in P19 embryonal carcinoma
cells and neuronal stem cells (Resende et al., 2008; Schwindt et al.,
2011). Ca2+-imaging-based pharmacological analysis revealed
that P2X4Rs or P2X4-containing heteromultimers mediate ATP-
induced calcium-responses of undifferentiated P19 embry-
onal carcinoma cells, while P2X2Rs and possibly heteromeric
P2X2/6Rs are the major mediators of calcium-responses in neu-
ronally differentiated cells after retinoic acid treatment (Resende
et al., 2008). However, it remained partially unresolved whether
the ATP-induced calcium transients of neuronally differenti-
ated P19 cells are mediated by homomeric P2X2 or heteromeric
P2X2/6Rs (Resende et al., 2008), although an simultaneous
upregulation of the P2X2 and P2X6 expression was shown during
neuronal differentiation (Resende et al., 2007). Also, during neu-
ronal differentiation of neuronal progenitor cells of neurospheres
the expression of P2X2 and P2X6 subunits was upregulated
(Schwindt et al., 2011). In summary, although P2X2 and P2X6 are
co-expressed in several tissues and their simultaneous regulation
during neuronal differentiation was shown, there is to our knowl-
edge no clear and direct evidence for the presence of functional
heterotrimeric P2X2/6 assemblies in native cells or tissues.
P2X4/6 HETEROMERS
Biochemical evidence
Biochemical evidence for the existence of P2X4/6 heteromers was
initially demonstrated by co-purification of epitope-tagged P2X4
and P2X6 subunits upon expression in HEK293 cells (Le et al.,
1998; Torres et al., 1999a). There is a controversy regarding the
ability of the P2X6 subtype to form homotrimers, since its expres-
sion in in vitro models failed to generate a functional receptor
(Soto et al., 1996b; Le et al., 1998; Khakh et al., 1999; Torres
et al., 1999a; King et al., 2000; Aschrafi et al., 2004). It has been
suggested that the P2X6 subtype needs to get posttranslationally
glycosylated to form a functional homomeric receptor in HEK293
cells (Jones et al., 2004). However, endogenous P2X4Rs have been
reported in HEK293 cells (Worthington et al., 1999) (own unpub-
lished observations) and could promote P2X6 subunit assembly
and trafficking in form of heteromers. Using AFM in combina-
tion with surface biotinylation and immunofluorescence analysis,
it has been shown that P2X6 subunits expressed in NRK cells do
not form homotrimers. Substitution of 14 uncharged N-terminal
amino acid residues by charged residues increased glycosylation
and plasma membrane insertion of P2X6 subunits, indicating
that their ER release is inhibited by this uncharged N-terminal
region (Ormond et al., 2006). Co-immunoprecipitation and
Frontiers in Cellular Neuroscience www.frontiersin.org December 2013 | Volume 7 | Article 250 | 11
Saul et al. P2X assembly
immunofluorescent studies in HEK293 cells showed a preferred
assembly of P2X4 subunits into heterotrimeric P2X4/6Rs (Le
et al., 1998; Bobanovic et al., 2002) and regulation of the P2X4/6
heteromer trafficking by the P2X4 subunit. The homomeric
P2X4R showed an intracellular punctate distribution with sparse
localization at the plasmamembrane. In contrast, the GFP-tagged
P2X6 subunit was diffusely distributed intracellularly and co-
localized with the ER marker calreticulin, without any indication
for the presence of the P2X6R at the cell surface. However, in the
presence of the P2X4 subunit, the P2X6 subunit showed a simi-
lar punctate pattern as the homomeric P2X4R (Bobanovic et al.,
2002).
Functional evidence
The functional differentiation between homomeric P2X4 and
heteromeric P2X4/6 assemblies is difficult, since the biophysical
and pharmacological differences are not that clear and contro-
verse data exist regarding the functional expression and αβ-
meATP sensitivity of the P2X6R (Collo et al., 1996; Jones et al.,
2004). The sensitivity of homomeric P2X4Rs to the partial ago-
nist αβ-meATP is relatively low and species-dependent with EC50
values of 7 and 19.2μM for mouse and human receptors, respec-
tively, whereas rat P2X4Rs showed only very weak responses
(Jones et al., 2000). Upon co-expression of P2X4 and P2X6 sub-
units in Xenopus oocytes, receptors were observed that showed
(1) a three to five fold higher sensitivity to the partial ago-
nists αβ-meATP and 2MeSATP than the P2X4R, (2) an enhanced
inhibition by PPADS, suramin, and RB-2, and (3) peak cur-
rent amplitudes that differed from those obtained by expression
of the P2X4 subunit alone. However, current kinetics and cur-
rent potentiation by IVM, as well as the effects of modulators
like protons and zinc ions were undistinguishable between P2X4
homomers and P2X4/6 heteromers (Le et al., 1998; Khakh et al.,
1999).
Evidence from native systems
P2X4 and P2X6 RNAs are abundant and show a broad overlap-
ping distribution throughout the central nervous system with
significant amounts in the hippocampus and the cerebellum
(Collo et al., 1996; Soto et al., 1996a,b). However, the func-
tion of homomeric P2X4 or heteromeric P2X4/6Rs in neurons
remains unclear. Immunogold-labeling demonstrated the pres-
ence of P2X4 and P2X6 subunits in perikarya and dendritic spines
of cerebellar Purkinje and hippocampal, pyramidal CA1 neu-
rons, where they were suggested to form heteromeric assemblies
(Rubio and Soto, 2001). Although P2X4 transcripts were found
in hippocampal CA1 pyramidal neurons, αβ-meATP induced
responses frommost CA1 neurons remained unaltered upon IVM
treatment, indicating that neither P2X4 homomers nor P2X4/6
heteromers are expressed in these cells (Khakh et al., 1999).
However, a possible role of the P2X4 subunit in regulating synap-
tic plasticity was suggested based on studies with P2X4 knockout
mice. The application of IVM on wt-mouse brain slices potenti-
ated the EPSPs from CA1 neurons, whereas IVM had no effect in
P2X4 knockout mice, which also showed an impaired long-term
potentiation in the hippocampus (Sim et al., 2006). Early studies
on rat hippocampal CA3 neurons revealed αβ-meATP-activated
responses that were blocked by suramin, but were insensitive to
PPADS (Ross et al., 1998), ruling out a contribution of P2X4Rs
or P2X4/6Rs to neuronal excitation in these neurons. These find-
ings were confirmed by later studies reporting that IVM had no
effect on these cells (Mori et al., 2001; Kondratskaya et al., 2008).
However, a significant contribution of P2X4 subunit-containing
receptors to the generation of EPSPs was shown in neocortical
neurons, where ATP- and αβ-meATP-mediated current responses
were potentiated by IVM, but were not inhibited by PPADS (Lalo
et al., 2007).
According to functional and biochemical analyses, P2X4 and
P2X6 subunits are endogenously expressed in P19murine embry-
onal carcinoma cells and show varying expression levels during
the non-differentiated and neuronal progenitor states, suggesting
a possible role for heteromeric P2X4/6Rs in regulation and induc-
tion of neurogenesis (Resende et al., 2007, 2008). P2X4 and P2X6
subtype expression was also found in human non-cystic and cys-
tic fibrosis epithelial cells. The knockdown of the P2X6 subunit
by siRNA in these cells resulted in a significant attenuation of
Zn2+-mediated Ca2+ influx, which was similar to the effect that
occurred upon P2X4 subunit knockdown (Liang et al., 2005).
Therefore, it was suggested that P2X4/6Rs play a role in the reg-
ulation of the Ca2+ influx that restores Cl− secretion across the
airway epithelia. Immunofluorescent stainings on human umbili-
cial endothelial cells revealed a colocalization of P2X4 and P2X6
subunits with VE-cadherin in cellular junctions, where they were
suggested to be involved in the modulation of cell-cell adhesion
processes via the mediation of Ca2+ signaling (Glass et al., 2002).
P2X4/7 HETEROMERS
P2X4R and P2X7R genes are located next to each other on human
and rat chromosome 12 and murine chromosome 5. Both sub-
units share a high sequence similarity and show overlapping
distribution in many tissues such as epithelia, endothelia, and
immune cells.
Biochemical evidence
Biochemical evidence for an association between P2X4 and P2X7
subunits was originally provided by co-immunoprecipitation
from transfected HEK cells and from bone marrow-derived
macrophages (Guo et al., 2007). Several subsequent studies, how-
ever, failed to confirm an association between both subunits
within heterotrimeric complexes: BN-PAGE analysis of P2X7
complexes from various native tissues (bone marrow, lymph
node, salivary gland) that contained both subunits revealed exclu-
sively complexes that corresponded in size to the homomeric
P2X7 complex, which can be differentiated by its size from any
heteromeric P2X7-containing complex (Nicke, 2008). Likewise,
BN-PAGE analysis and cross-linking data from primary cultures
of rat macrophages and mouse microglia revealed an inter-
action between homomeric P2X7 and P2X4 complexes rather
than P2X4/7 heteromers (Boumechache et al., 2009). This study
further showed that P2X4Rs were predominantly intracellular,
whereas P2X7Rs were mainly localized to the plasma membrane.
However, both complexes could be co-immunoprecipitated. Co-
expression of P2X4 and P2X7 subunits in NRK cells increased
the surface expression of P2X4 subunits about two-fold (Guo
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et al., 2007). A pairing of P2X4 and P2X7 (and also P2X2 and
P2X4) homotrimers was supported by cross-linking analysis and
AFM imaging of HEK cell-expressed receptors (Antonio et al.,
2011). In conclusion, there is currently no biochemical evidence
for the presence of heterotrimeric P2X7Rs. It has to be noted,
however, that P2X2 and P2X4 receptors have been found to
be rather “sticky” proteins that appear to associate into higher
aggregates more easily than other subunits (Aschrafi et al., 2004;
Weinhold et al., 2010) (observation from the authors labs) and
also P2X1 trimers appear to associate into dimers and higher
complexes under certain conditions (Nicke, 2008). Whether this
represents an expression-level and/or detergent-dependent arte-
fact or is the result of a specific interaction is not clear at present.
In the mouse alveolar epithelial E10 cell line, P2X4 and P2X7
receptors were shown to associate partly with lipid rafts and the
P2X7R was found to interact with caveolin 1 (Barth et al., 2008).
Co-immunoprecipitation, high resolution clear native PAGE, and
BN-PAGE data suggest that all three proteins can be constituents
of higher order protein complexes in these cells, but that caveolin
1 interacts only with P2X7Rs directly. In support of this, knock
down by shRNAs demonstrated that downregulation of P2X7
subunits affects protein levels, localization, and complex organi-
zation of both caveolin 1 and P2X4. In contrast, P2X4 knock-
down affected only P2X7 protein levels and localization but not
caveolin 1 (Weinhold et al., 2010). In both cases, upregulation of
the respective other P2X subunit was found. In the kidney, how-
ever, a mutual negative influence on subunit expression levels was
found (Craigie et al., 2013). Using the respective knockout mice,
it was shown that ablation of one subunit significantly reduced
the mRNA levels of the respective other subunit.
Functional evidence for mutual interactions
Functional evidence for mutual interactions between P2X4 and
P2X7 subunits and/or receptors has been found in HEK cells co-
transfected with both subunits (Guo et al., 2007; Casas-Pruneda
et al., 2009). Thus, co-expression of a dominant negative P2X4
subunit was found to reduce the P2X7R currents without reduc-
ing their number in the plasma membrane and to confer IVM
and TNP-ATP sensitivity as well as some BBG resistance to the
P2X7R (Guo et al., 2007). In another study, the ATP-activated
current decay in TEA+-containing solution was accelerated by co-
expression of P2X4 subunits, which themselves showed no cur-
rent under these ionic conditions. Furthermore, ethidium uptake
was slowed down and decreased, a P2X fraction with lower ATP-
sensitivity was observed, and a concentration-dependent lack of
potentiation by IVM was seen in the presence of P2X4 subunits
(Casas-Pruneda et al., 2009).
Evidence from native systems
Co-expression of mouse P2X4 and P2X7 subunits in HEK cells
reproduced the properties of ATP-activated currents in parotid
acinar cells better than expression of each subunit alone (Casas-
Pruneda et al., 2009). In freshly isolated rabbit airway ciliated cells
an ATP-gated cation channel has been characterized (Ma et al.,
2006) that shares the following properties with the P2X7R but not
the P2X4R: (a) low sensitivity to ATP, (b) modulation by external
Na+, (c) inhibition by extracellular divalent cations as well as (d)
sensitivity to the P2X7 antagonists BBG and KN-62. However, in
contrast to the P2X7R, this P2X(cilia) did not show pore dilation
and, in agreement with P2X4R-associated properties, its current
was augmented by Zn2+ and IVM. A mixture of both homo-
meric channels was excluded because the dose response curve
of this channel could be described by a simple Hill equation
and a P2X4/7R heteromer or a modified P2X4R were proposed
as possible explanations. In support of a homomeric P2X7R,
however, it was recently found that IVM also species-specifically
potentiates P2X7R current amplitudes in a very similar man-
ner as described for the P2X(cilia) (Casas-Pruneda et al., 2009;
Nörenberg et al., 2010), see also Surprenant and North (2009).
Adding to the complexity of P2X7R characterization, polymor-
phisms have been identified in human and mouse P2X7 isoforms
that influence their ability to form dye permeable pores, at least
when studied in native cell preparations (Gu et al., 2001; Adriouch
et al., 2002; Le Stunff et al., 2004; Sorge et al., 2012). It has to
be noted, however, that no obvious functional differences were
found if the respective recombinant channels were studied (Boldt
et al., 2003; Donnelly-Roberts et al., 2009; Schwarz et al., 2012;
Xu et al., 2012), suggesting the involvement of cell-specific fac-
tors in pore formation and/or assay-dependent/methodological
differences in these studies. Thus, species-specific differences in
pharmacology as well as polymorphisms need to be considered
when characterizing P2X7Rs in native tissues.
Functional interactions between both receptors were recently
also shown in mouse macrophage RAW246.7 cells, where P2X4
knock down by shRNA suppressed ATP-induced cell death and
release of HMGB1 and Il1β, and facilitated the production of
reactive oxygen species. However, P2X4 subunit knock down
did not affect P2X7-mediated pore formation and MAPK sig-
naling (Kawano et al., 2012a,b). From similar experiments,
it was suggested that the P2X4R positively modulates P2X7-
dependent cytokine release from bone marrow-derived dendritic
cells (Sakaki et al., 2013). Most recently, a supposedly P2X4-
containing receptor was described in murine myenteric neurons.
Compared to the homomeric P2X4R this receptor had lower ATP
sensitivity but increased sensitivity to the antagonists PPADS and
suramin and its current was potentiated by IVM. Since P2X2
and P2X7 subunits had also been reported to be expressed in
these cells, the possibility of P2X2/4/7 heteromers was considered
(Maria et al., 2013).
EVIDENCE FOR CLUSTERING OF TRIMERIC P2XRs
For heterologously expressed P2X2Rs it was observed that prop-
erties such as mean open times, open channel noise, poten-
tiation by Zn2+ and pH, the EC50 value for ATP, the ability
to form large pores, and the inward rectification depend on
the P2X2 expression level or density (Ding and Sachs, 2002;
Clyne et al., 2003; Fujiwara and Kubo, 2004), suggesting inter-
actions between homotrimeric P2X2Rs. A physical interaction
between P2X2Rs is supported by biochemical evidence for an
increased tendency of this receptor to form higher order com-
plexes (Aschrafi et al., 2004) and high densities of GFP-tagged
P2X2Rs could be observed upon their activation-dependent clus-
tering in embryonic hippocampal neurons (Khakh et al., 2001). In
addition, physical interactions between homotrimeric P2X7 and
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P2X4 receptors, and P2X2 and P2X4 receptors have been observed
(Boumechache et al., 2009; Antonio et al., 2011). Whether these
interactions are direct or via clustering molecules or within lipid
domains and whether they have physiological relevance or rep-
resent overexpression artefacts remains to be determined. In this
context, it is interesting that P2X4 and P2X7 were co-precipitated
with the extracellular matrix component biglycan and soluble
biglycan-induced clustering of P2X4 and P2X7 receptors with
Toll-like receptor (TLR) 2/4 was found to underlie the activation
of the inflammasome by this component (Babelova et al., 2009).
Functional and physical interactions between P2XRs and other
ion channels (e.g., members of the Cys-loop receptor and epithe-
lial Na+ channel families) have also been described [for a recent
review see (Kaczmarek-Hajek et al., 2012)].
SUMMARY AND OUTLOOK
P2XRs contain three intersubunit binding sites for orthosteric
ligands. In heteromeric receptors all three binding sites differ sig-
nificantly and thus offer theoretically the possibility for subtype-
specific targeting of heteromers. However, proof of this concept is
still lacking.
For heterologously expressed receptors, a combination of
pharmacology and current kinetics in most cases allowed the
discrimination of heteromeric receptor responses from those
of homomeric receptors. However, identification of matching
responses in native cells proved difficult and was only convinc-
ingly achieved in case of the P2X1/5 and P2X2/3 heteromers.
Thus, it is likely that additional factors such as receptor modifica-
tions (e.g., phosphorylation), P2X splice variants, interacting pro-
teins, P2XR clustering, the physiological expression background,
expression levels, and trafficking influence P2XR properties under
native conditions.
Co-immunoprecipitation still represents one of the standard
experiments to proof a physical interaction between proteins.
However, several pitfalls need to be considered: First, the method
does not allow to differentiate between association of trimeric
receptors and heterotrimerization of subunits. Second, it is dif-
ficult to exclude that the observed interaction is due to artificial
aggregation of the overexpressed protein or occurs artificially dur-
ing the solubilization and purification process, which is generally
optimized toward the detection of an interaction. Third, if per-
formed in native tissues, this method also critically depends on
the availability of reliable antibodies. Thus, methods for the direct
visualization of complexes and biochemical and/or functional
assays, which are able to detect interactions within themembrane,
are needed and experiments should preferably be performed on
native preparations or at physiological expression levels. With
RNA knockdown technology, knockout animals, and transgenic
animals expressing tagged P2XRs, suitable control experiments
can be performed and in combination with the increasingly
available subtype selective compounds, knockout animals pro-
vide valuable models to decipher the composition of heteromeric
complexes by pharmacological means.
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